The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

24 Sep 2015 07:00

RNS Number : 0283A
Falanx Group Limited
24 September 2015
 



 FALANX GROUP LIMITED

 

24 September, 2015

("Falanx" or "the Company")

Falanx Operational Update

 

· Agreements in place to become preferred cyber security provider to three regulated financial services companies

· Achieved ISO/IEC 20000-1, ISO/IEC 27001 and ISO 9001 accreditation

· Five new corporate intelligence contracts signed

 

Falanx Group Limited, a security and risk management consultancy working with blue chip and government clients worldwide, is pleased to provide the following operational update.

 

Falanx Cyber

Falanx Cyber, operating under the Falanx Assuria brand, formally launched its new Cyber Defence managed service in March 2015. Since then Falanx has entered into agreement with three regulated financial services companies to become their preferred cyber security provider. This involves Falanx working with an international trading bank with interests in East Africa, the US and Europe to help the bank to put in place US/UK-compliant operating and reporting platforms in various geographies. Falanx will also work with two financial advisory boutiques to provide cyber security for their and their clients' businesses.

Falanx is also delighted to announce it has now achieved ISO 9001, /IEC 20000-1 and ISO/IEC 27001 accreditation. These accreditations will enable Falanx to pursue major contracts with UK Government agencies, regulators and multi-nationals.

 

The investment made into the sales and marketing team is bearing fruit with a growing pipeline and a number of opportunities at various stages of development.

 

Falanx Intelligence

Falanx Intelligence, operating under the Stirling Assynt brand, has recently secured contracts with:

· A global trade, shipping and energy conglomerate

· A leading oil and gas producer

· An international financial services company

· Two multi-national communications and information technology companies

 

Falanx Intelligence has also undertaken an increasing number of special projects, amounting to £350K in the financial year to date. 

 

Falanx Resilience

The consultancy pipeline is becoming increasingly strong with negotiations for some interesting contracts progressing well. The Company will update shareholders as further progress is made.

 

Issue of shares

Falanx Group Limited announces that it has issued 200,000 Ordinary Shares to Emma Shaw, Non-Executive director of the Company. These shares were issued under Emma Shaw's appointment letter dated 11 January 2013. In 2013 when the Group was formed and listed on AIM the Non-Executive Directors were entitled under their appointment letters to an allocation of 200,000 shares in the company.

 

Following the issue of these shares, Emma Shaw will hold 200,000 Ordinary Shares representing 0.28 per cent of the issued share capital of the Company.

 

Application has been made for the 200,000 Ordinary Shares to be admitted to trading on AIM, which is expected to occur on 25 September 2015. Following issue of the new shares, the Company will have a total of 71,255,368 Ordinary Shares in issue.

  

Total Voting Rights

 

The Company holds no Ordinary Shares in treasury. Therefore the total number of ordinary shares with voting rights is 71,255,368 which figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

John Blamire CEO of Falanx Group commented:

 

"We have invested in expanding our sales team, and this is already starting to pay dividends with an increase in contracts signed, and further opportunities that we are currently pursuing. We are also pleased to report that our customer relations management has become more effective improving the coordination of our sales activity across the Group.

 

The risks presented by cybercrime have been brought into sharp focus in recent months, and companies are increasingly aware of the importance of security and risk management. We now have the team in place to maximise the opportunity that this presents, and we look forward to keeping shareholders informed as we sign more contracts."

 

Enquiries:

Falanx Group Limited

John Blamire, Chief Executive

www.falanxgroup.com

www.falanxassuria.com

+ 44 (0) 20 7856 9457

 

Charles Stanley Securities

Nominated Adviser & Broker

+44 (0) 207 149 6000

Mark Taylor

Redleaf PR

Rebecca Sanders-Hewett

Charlie Geller

Susie Hudson

 

+44 (0) 207 382 4730 

falanx@redleafpr.com 

Notes to Editors:

 

About Falanx Group

 

§ Falanx Group Limited is a global intelligence, security and cyber defence provider working with blue chip and government clients.

 

§ The Group has three business divisions:

- Falanx Intelligence: Political & Security Risk and Business Intelligence services

- Falanx Resilience: Security Consultancy, Crisis Management and asset and facility security

- Falanx Cyber: Comprehensive cloud-based cyber security services

 

§ The Group listed on AIM in June 2013 under ticker FLX.

 

§ For more information: http://www.falanxgroup.com/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGGBUPAGRW
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.